In mouse colorectal cancer models, neutrophil-secreted MMP-9 activates latent TGFβ in the ECM by degrading the ECM, increasing the level of TGFβ in the tumor microenvironment, and thereby inhibiting antitumor T cell response [40]. This evidence concerns the gene MMP9 and neoplasm.